Skip to main content
. 2020 Aug 20;21(17):6002. doi: 10.3390/ijms21176002

Figure 1.

Figure 1

Drugs currently under clinical trials for COVID-19 treatment: ritonavir (1), lopinavir (2), azithromycin (3), remdesivir (4), and the anti-malaria drug hydroxychloroquine (5). All bear ionizable functionalities.